These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 6264560

  • 21. [Partial Addison's disease].
    Oki S.
    Nihon Rinsho; 2006 May 28; Suppl 1():578-81. PubMed ID: 16776220
    [No Abstract] [Full Text] [Related]

  • 22. [A case of Addison's disease in a dog (author's transl)].
    Baarschers JJ, Hommes UE, Poll PH.
    Tijdschr Diergeneeskd; 1975 Aug 15; 100(16):894-6. PubMed ID: 170705
    [No Abstract] [Full Text] [Related]

  • 23. Biochemical testing of adrenocortical function.
    Rosalki SB.
    Int J Clin Pract; 1998 Aug 15; 52(3):189-91. PubMed ID: 9684436
    [Abstract] [Full Text] [Related]

  • 24. Adrenocortical response to ACTH in Addison's disease.
    Tyler FH.
    N Engl J Med; 1973 Apr 19; 288(16):854-5. PubMed ID: 4348411
    [No Abstract] [Full Text] [Related]

  • 25. Addison's disease.
    Nieman LK, Chanco Turner ML.
    Clin Dermatol; 2006 Apr 19; 24(4):276-80. PubMed ID: 16828409
    [Abstract] [Full Text] [Related]

  • 26. [Restoration of adrenal cortex function in a patient with Addison's disease of 20-years' duration].
    Zefirova GS, Rybakova LM, Tslakh ZZ.
    Ter Arkh; 1984 Apr 19; 56(11):128-9. PubMed ID: 6523377
    [No Abstract] [Full Text] [Related]

  • 27. Addison's disease.
    Davenport J, Kellerman C, Reiss D, Harrison L.
    Am Fam Physician; 1991 Apr 19; 43(4):1338-42. PubMed ID: 2008821
    [Abstract] [Full Text] [Related]

  • 28. Long-lasting subclinical Addison's disease.
    Torrejón S, Webb SM, Rodríguez-Espinosa J, Martínez de Osaba MJ, Corcoy R.
    Exp Clin Endocrinol Diabetes; 2007 Sep 19; 115(8):530-2. PubMed ID: 17853338
    [Abstract] [Full Text] [Related]

  • 29. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL, Lewis JG, Rees LH.
    Clin Endocrinol (Oxf); 1978 Aug 19; 9(2):131-9. PubMed ID: 212238
    [Abstract] [Full Text] [Related]

  • 30. Effect of atrial natriuretic factor on basal and stimulated pituitary-adrenal function in Cushing's and Addison's disease.
    Sala C, Ambrosi B, Colombo P, Ardeleani G, Bochicchio D, Gazzano G, Zanchetti A, Morganti A.
    J Hypertens Suppl; 1993 Dec 19; 11(5):S312-3. PubMed ID: 8158401
    [No Abstract] [Full Text] [Related]

  • 31. [Follow-up in Addison's disease].
    Estopiñán García V, Martínez Burgui JA, Majó Llopart J, Chilet Navarro I.
    An Med Interna; 2002 Jun 19; 19(6):324-5. PubMed ID: 12152397
    [No Abstract] [Full Text] [Related]

  • 32. [Nil value of corticotropic hormone determination in the follow-up of Addison's disease].
    Estopiñán V, Gracia P, Fortea L.
    Med Clin (Barc); 1990 May 05; 94(17):679. PubMed ID: 2166889
    [No Abstract] [Full Text] [Related]

  • 33. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, Pastore G.
    Pediatr Blood Cancer; 2008 Mar 05; 50(3):537-41. PubMed ID: 17828747
    [Abstract] [Full Text] [Related]

  • 34. [Addison disease during pregnancy--a diagnostic dilemma. Symptoms are similar to normal pregnancy problems].
    Wålinder O.
    Lakartidningen; 2008 Mar 05; 102(26-27):1988-90. PubMed ID: 16044755
    [Abstract] [Full Text] [Related]

  • 35. The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison's disease.
    Krieger DT, Gewirtz GP.
    J Clin Endocrinol Metab; 1974 Jul 05; 39(1):46-52. PubMed ID: 4365917
    [No Abstract] [Full Text] [Related]

  • 36. [Inhibition of ACTH hypersecretion in Addison's disease by serotonin-antagonistic agents].
    Fehm HL, Voigt KH, Kummer G, Retiene K, Pfeiffer EF.
    Verh Dtsch Ges Inn Med; 1978 Jul 05; (84):1463-5. PubMed ID: 217195
    [No Abstract] [Full Text] [Related]

  • 37. Suppression of plasma ACTH levels with corticosteroids in Addison's disease.
    Holdaway IM.
    Clin Endocrinol (Oxf); 1973 Jan 05; 2(1):37-42. PubMed ID: 4358776
    [No Abstract] [Full Text] [Related]

  • 38. [How should the plasma ACTH level in treated Addison's disease patients be interpreted?].
    Pehuet-Figoni M, Bertagna X, Girard F, Bricaire H, Luton JP.
    Ann Endocrinol (Paris); 1989 Jan 05; 50(1):54-7. PubMed ID: 2543260
    [Abstract] [Full Text] [Related]

  • 39. Assessment of adrenal function by measurement of salivary steroids in response to corticotrophin in patients infected with human immunodeficiency virus.
    Cardoso E, Persi G, González N, Tumilasci O, Arregger A, Burgos M, Rodríguez V, Molina A, Contreras LN.
    Steroids; 2007 Apr 05; 72(4):328-34. PubMed ID: 17257634
    [Abstract] [Full Text] [Related]

  • 40. Recovery of adrenocortical function following treatment of tuberculous Addison's disease.
    Keleştimur F.
    Postgrad Med J; 1993 Oct 05; 69(816):832. PubMed ID: 8290424
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.